# A Study of AK146D1 for Injection in Advanced Solid Tumors

> **NCT07067567** · PHASE1 · RECRUITING · sponsor: **Akeso** · enrollment: 200 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** AK146D1 for injection

## Key facts

- **NCT ID:** NCT07067567
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-07
- **Primary completion:** 2026-11-05
- **Final completion:** 2027-05-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07067567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07067567, "A Study of AK146D1 for Injection in Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07067567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*